top of page

Clinical Research

Along with normal clinical service,  wide range of clinical trials also provided in our center

We are actively recruiting patient to participate in the following clinical trials

Please send referral letter to  if interested

Recruiting Clinical Trials 

Liver Cancer

Protocol Number

Protocol Title

Experimental Agent

Principle Investigator


A Phase 1/2, Safety Confirmation and Double-blind, Placebo-controlled, Randomized Study of Relatlimab in Combination with Nivolumab and Bevacizumab in Treatment-naive Advanced/Metastatic Hepatocellular Carcinoma (RELATIVITY-106)

Relatilimab + Nivolumab + Bevacizumab

CO44668  (IMbrave152)

A Phase III, Randomized, Double-blind, Placebo-controlled Study Evaluation Atezolizumab and Bevacizumab, with or without Tiragolumab, in Patients with Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma

 Nivolumab + Bevacizumab +/- Tiragolumab


A Phase 1/2 open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary antitumor activity of OTX-2002 as a single agent and in combination with standard of care in patients with hepatocellular carcinoma and other solid tumor types known for association with the MYC oncogene.


bottom of page